January 21, 2025
By Brandon Chase Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH). To […]
January 19, 2025
Abstract Background Risk estimation is an essential component of cardiovascular disease prevention among people with HIV. We aimed to characterise how well atherosclerotic cardiovascular disease (ASCVD) […]
January 16, 2025
Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that […]
January 16, 2025
By: Liz Highleyman Taking a statin can help stabilize coronary artery plaque, reducing the risk that it will rupture and cause a heart attack or stroke, […]
December 11, 2024
Abstract Importance In a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but […]
October 11, 2024
Abstract Background: Among people with HIV (PWH), COVID-19 is common and potentially severe. We leveraged REPRIEVE to assess the effects of statin therapy for cardiovascular disease […]
October 9, 2024
By: Michael Monostra In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those […]
October 9, 2024
Data from the REPRIEVE trial suggest there is only a minimal increased risk of diabetes with statins among people with HIV, and in specific, limited groups […]
October 8, 2024
Abstract Background: REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) led to new guidelines for statin use among people with HIV (PWH) with low to […]
January 21, 2025
By Brandon Chase Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV (PWH). To […]
January 19, 2025
Abstract Background Risk estimation is an essential component of cardiovascular disease prevention among people with HIV. We aimed to characterise how well atherosclerotic cardiovascular disease (ASCVD) […]
January 16, 2025
Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that […]
January 16, 2025
By: Liz Highleyman Taking a statin can help stabilize coronary artery plaque, reducing the risk that it will rupture and cause a heart attack or stroke, […]
December 11, 2024
Abstract Importance In a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but […]
October 11, 2024
Abstract Background: Among people with HIV (PWH), COVID-19 is common and potentially severe. We leveraged REPRIEVE to assess the effects of statin therapy for cardiovascular disease […]
October 9, 2024
By: Michael Monostra In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those […]
October 9, 2024
Data from the REPRIEVE trial suggest there is only a minimal increased risk of diabetes with statins among people with HIV, and in specific, limited groups […]
October 8, 2024
Abstract Background: REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) led to new guidelines for statin use among people with HIV (PWH) with low to […]